The Medicaid Reimbursement Gap: The Margin That Never Reaches EBITDA

Multi-state expansion in specialty healthcare often appears straightforward on a pro forma. A new state, a defined population, and a reimbursement rate from the Medicaid fee schedule can make the expansion model look favorable and secure board approval. But the reimbursement gap — the difference between the modeled rate and the margin that actually reaches your EBITDA — is real, varies by state, and is largely driven by payer-rule complexity that standard underwriting overlooks.

For ABA and specialty behavioral health operators, that gap is significant. For PE-backed groups managing multi-state portfolios, it multiplies with every new market you enter. The factors that drive it — Medicaid managed care penetration, authorization lag, credentialing timelines, and modifier collision — rarely appear as discrete quantified costs in a pre-expansion financial model.

Medicaid reimburses specialty healthcare services differently in every state. While rate variation is significant, structural differences are more impactful. Each state Medicaid program has unique managed care contracts, authorization requirements, unit definitions, and modifier rules. A CPT code that is reimbursed in one state may require a different unit structure, place-of-service designation, or additional authorization in another.

Medicaid's role in specialty behavioral health is the dominant payer relationship of the sector. Medicaid and Medicare together account for 58 percent of U.S. behavioral health care expenditures, with Medicaid being the largest single payer of behavioral health services, according to the National Academies of Sciences' 2024 report, Improving Access to and Equity of Care for People with Serious Mental Illness. Within ABA therapy specifically, the growth trajectory has been steep: Medicaid-covered ABA service delivery grew 298% between 2019 and 2024, outpacing commercial growth of 249% over the same period, according to Trilliant Health's 2024 national claims analysis. For multi-site operators, that trajectory means Medicaid concentration is increasing across your portfolio as you expand — with it, exposure to state-specific payer-rule variance that standard financial modeling does not price in.

Administrative costs for managing Medicaid claims increase with scale, and they scale non-linearly. The cost of a denied Medicaid claim is not just the resubmission labor; it is the cash flow delay, the write-off risk, and the compounding effect across a high-volume multi-state book. Research consistently shows that Medicaid generates far higher administrative cost burdens per claim than Medicare or commercial payers, driven by the complexity of managed care contracts, authorization requirements, and state-specific modifier rules. For PE-backed groups entering new states, these costs are seldom modeled in detail before acquisition.

Standard multi-state healthcare expansion strategy models account for reimbursement rates, projected patient volume, staffing, and facility costs. For PE-backed groups, these models typically inform board approval and LOI decisions. Medicaid managed care penetration, credentialing timelines, authorization lag, and payer-rule variance rarely appear as their own discrete, quantified costs in a pre-expansion financial model. But, each flows directly to net collections, cost-to-collect ratios, and ultimately EBITDA.

Multi-state healthcare expansion strategies often underestimate the following factors.

Authorization lag

Many state Medicaid programs and their managed care organizations have Medicaid prior authorization behavioral health timelines of 30 to 90 days for new ABA cases. Revenue cannot be recognized until authorization is granted, regardless of provider readiness.

Payer-rule collision

When multi-state groups standardize revenue cycle workflows, state-specific rules can lead to undetected denial patterns. For example, a modifier billable in Florida may not be covered in Ohio for the same clinical scenario. By the time a multi-state RCM team identifies the pattern, it may have grown across a full billing quarter.

Credentialing asymmetry

State Medicaid enrollment timelines for new providers vary widely. Revenue cycle teams in new markets often bill during provisional credentialing periods, which can create retroactive financial and compliance risks if enrollment is not completed properly.

Secondary payer complexity

For individuals with both Medicaid and commercial coverage, coordination of benefits rules differ by state. Revenue that seems secured from the commercial payer may be subject to clawback if Medicaid secondary rules are not correctly applied at the claim level.

Before entering a new market, include a payer-complexity assessment alongside the standard financial model. For each target state, evaluate the following:

How do I model Medicaid reimbursement before expanding into a new state?

Start by building a payer-complexity layer into your standard financial model. For each target state, assess Medicaid managed care penetration, prior authorization timelines, and denial rate benchmarks using claims-level data from your existing markets. Published fee schedule rates are a starting point, not a finish line. Net collections against your actual denial and adjustment history will give you the real reimbursement picture.

What are the Medicaid reimbursement differences by state for ABA providers?

Differences go beyond the published rate. Each state Medicaid program operates under its own managed care contracts, modifier rules, unit definitions, and authorization requirements. A CPT code reimbursed cleanly in one state may require additional authorization steps or a different unit structure in another. The operational cost of navigating those differences is rarely captured in a pre-expansion model.

What should a PE-backed healthcare clinic consider before expanding into a new state?

Beyond the standard financial model, PE-backed groups should pressure-test Medicaid managed care penetration, credentialing timelines, authorization lag, and payer-rule variance in the target state. These factors directly affect net collections and cost-to-collect ratios, both of which flow to EBITDA. The economics of a new market can look materially different once operational complexity is priced in.

How does Medicaid managed care penetration affect specialty healthcare operators?

In states with high managed care penetration, operators face an additional contracting layer beyond the state fee schedule. Each managed care organization carries its own authorization requirements, rate structures, and denial logic. For multi-state groups standardizing revenue cycle workflows, this variance is a common source of undetected denial patterns and margin erosion.

Why do multi-state healthcare operators struggle with Medicaid reimbursement consistency?

Because Medicaid is a state-administered program, no two states operate identically. Authorization rules, modifier logic, credentialing timelines, and coordination of benefits requirements all vary. When a multi-state operator applies a standardized revenue cycle approach across markets, state-specific rules create gaps that accumulate quietly in denial rates, resubmission cycles, and delayed cash flow before the RCM function identifies the root cause.